References
Wenzel, S.E. Nat. Med. 18, 716–725 (2012).
Lambrecht, B.N. & Hammad, H. Lancet 376, 835–843 (2010).
Jatakanon, A., Lim, S. & Barnes, P.J. Am. J. Respir. Crit. Care Med. 161, 64–72 (2000).
Pavord, I.D. et al. Lancet 380, 651–659 (2012).
Mjösberg, J.M. et al. Nat. Immunol. 12, 1055–1062 (2011).
Walker, J.A., Barlow, J.L. & McKenzie, A.N. Nat. Rev. Immunol. 13, 75–87 (2013).
Spits, H. et al. Nat. Rev. Immunol. 13, 145–149 (2013).
Barnig, C. et al. Sci. Transl. Med. 5, 174ra26 (2013).
Moffatt, M.F. et al. N. Engl. J. Med. 363, 1211–1221 (2010).
Bartemes, K.R. et al. J. Immunol. 188, 1503–1513 (2012).
Kim, H.Y. et al. J. Allergy Clin. Immunol. 129, 216–227 (2012).
Chang, Y.J. et al. Nat. Immunol. 12, 631–638 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Brusselle, G., Maes, T. & Bracke, K. Eosinophils in the Spotlight: Eosinophilic airway inflammation in nonallergic asthma. Nat Med 19, 977–979 (2013). https://doi.org/10.1038/nm.3300
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3300
- Springer Nature America, Inc.
This article is cited by
-
Influence of the environment on the characteristics of asthma
Scientific Reports (2022)
-
The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target IL-5 receptor alpha to negatively regulate eosinophilic airway inflammation
Cellular & Molecular Immunology (2022)
-
Interleukin-33 and thymic stromal lymphopoietin, but not interleukin-25, are crucial for development of airway eosinophilia induced by chitin
Scientific Reports (2021)
-
Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators
Inflammopharmacology (2021)
-
Role of interleukin-23 in the development of nonallergic eosinophilic inflammation in a murine model of asthma
Experimental & Molecular Medicine (2020)